These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8309507)

  • 21. Verification of carrier status for Becker muscular dystrophy from analysis of a blighted ovum.
    Wilton SD; Goldblatt J; Laing NG
    Prenat Diagn; 1993 Aug; 13(8):757-62. PubMed ID: 8284293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of dystrophin genomic and cDNA probes for solving difficulties in carrier detection and prenatal diagnosis of Duchenne muscular dystrophy.
    Shomrat R; Driks N; Legum C; Shiloh Y
    Am J Med Genet; 1992 Feb; 42(3):281-7. PubMed ID: 1536162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescent multiplex linkage analysis and carrier detection for Duchenne/Becker muscular dystrophy.
    Schwartz LS; Tarleton J; Popovich B; Seltzer WK; Hoffman EP
    Am J Hum Genet; 1992 Oct; 51(4):721-9. PubMed ID: 1415217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales.
    Norman A; Harper P
    Clin Genet; 1989 Jul; 36(1):31-7. PubMed ID: 2766561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-blind study of dystrophin staining in carriers of Duchenne muscular dystrophy.
    Bernier FP; Greenberg CR; Halliday WC; Wrogemann K
    Can J Neurol Sci; 1993 Feb; 20(1):44-7. PubMed ID: 8467428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling.
    Bushby K; Goodship J; Haggerty D; Heald A; Walls T
    Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization.
    Rosenberg C; Navajas L; Vagenas DF; Bakker E; Vainzof M; Passos-Bueno MR; Takata RI; Van Ommen GJ; Zatz M; Den Dunnen JT
    Neuromuscul Disord; 1998 Oct; 8(7):447-52. PubMed ID: 9829273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duchenne and Becker muscular dystrophies: an Estonian experience.
    Talkop UA; Klaassen T; Piirsoo A; Sander V; Napa A; Essenson E; Tammur J; Talvik T
    Brain Dev; 1999 Jun; 21(4):244-7. PubMed ID: 10392746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The differential diagnosis of the human dystrophinopathies and related disorders.
    Kakulas BA
    Curr Opin Neurol; 1996 Oct; 9(5):380-8. PubMed ID: 8894415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).
    Zatz M; Shapiro LJ; Campion DS; Kaback MM; Otto PA
    J Neurol Sci; 1980 Jun; 46(3):267-79. PubMed ID: 7381516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carrier detection in X-linked Becker muscular dystrophy by muscle provocation test (MPT).
    Herrmann FH; Spiegler AW
    J Neurol Sci; 1983 Dec; 62(1-3):141-6. PubMed ID: 6668470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Duchenne and Becker muscular dystrophy in Chile].
    Holmgren J; Reyes J; Colombo M; Blanco MA
    Rev Med Chil; 1992 Mar; 120(3):288-92. PubMed ID: 1342481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletions in the dystrophin gene: analysis of Duchenne and Becker muscular dystrophy patients in Quebec.
    Simard LR; Gingras F; Delvoye N; Vanasse M; Melançon SB; Labuda D
    Hum Genet; 1992 Jun; 89(4):419-24. PubMed ID: 1618490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Difference of new mutation rates in dystrophin gene between deletion and duplication mutation in Duchenne and Becker muscular dystrophy].
    Kawamura J; Kato S; Ishihara T; Hiraishi Y; Kawashiro T
    Rinsho Shinkeigaku; 1997 Mar; 37(3):212-7. PubMed ID: 9217419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular study of Duchenne and Becker muscular dystrophies in Japanese.
    Tsukamoto H; Inui K; Fukushima H; Nishigaki T; Taniike M; Tanaka J; Okada S
    J Inherit Metab Dis; 1991; 14(5):819-24. PubMed ID: 1779629
    [No Abstract]   [Full Text] [Related]  

  • 36. Estimate of the intrafamilial correlation for serum creatine kinase and pyruvate kinase in females at risk for Duchenne and Becker muscular dystrophies.
    Rabbi-Bortolini E; Dal Colletto GM; Passos-Bueno MR; Vainzof M; Rapaport D; Zatz M
    Hum Hered; 1991; 41(6):370-8. PubMed ID: 1797630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of carriers of deletions in the dystrophin gene in Bulgarian DMD-BMD families.
    Bronzova J; Todorova A; Kalaydjieva L
    Hum Genet; 1994 Feb; 93(2):170-4. PubMed ID: 8112741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dilating cardiomyopathy as the expression of Xp21 Becker type muscular dystrophy.
    Palmucci L; Doriguzzi C; Mongini T; Chiadò-Piat L; Restagno G; Carbonara A; Paolillo V
    J Neurol Sci; 1992 Sep; 111(2):218-21. PubMed ID: 1431989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular human genetics and the Duchenne/Becker muscular dystrophy gene.
    Monaco AP
    Mol Cell Biol Hum Dis Ser; 1993; 3():1-11. PubMed ID: 8111535
    [No Abstract]   [Full Text] [Related]  

  • 40. Dystrophin abnormality in progressive muscular dystrophy--a review article.
    Arahata K
    Acta Paediatr Jpn; 1991 Apr; 33(2):216-21. PubMed ID: 1957648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.